FIELD: medicine, pharmaceutics.
SUBSTANCE: tetra-(meso-aryl)porphyrin with diisobornylphenol substitutes of formula I , wherein the isobornyl fragments are configured as chiral centres (1S,2R,4R,1'R,2'S,4'S) or (1S,2R,4R,1'S,2'R,4'R) and (1R,2S,4S,1'R,2'S,4'S).
EFFECT: compound is of interest as a biologically active substance and hybrid antioxidant, and may be used in medicine.
1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
HYBRID TERPENOPHENOLS WITH ISOBORNYL AND 1-PHENYLETHYL OR 1-PHENYLPROPYL SUBSTITUENTS AND THEIR APPLICATION AS AGENT, POSSESSING ANTI-RADICAL, ANTIOXIDANT AND MEMBRANE-PROTECTION ACTIVITY | 2016 |
|
RU2642062C2 |
OMEGA-(HYDROXYARYL) ALKYLSULPHIDES BASED ON 2-IZOBORNYL-6-METHYL-4-PROPYLPHENOL | 2016 |
|
RU2616618C1 |
2,6-DIISOBORNYL PHENOL DERIVATIVES | 2011 |
|
RU2575294C2 |
CHIRAL ZINC COMPLEXES WITH ETHYLENEDIAMINE TERPENE DERIVATIVES | 2022 |
|
RU2785281C1 |
CHIRAL COPPER(II) COMPLEXES WITH TERPENIC DERIVATIVES OF ETHYLENEDIAMINE AND APPLICATION THEREOF AS AGENT EXHIBITING ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY | 2020 |
|
RU2756043C1 |
2,6-DIISOBORNYLPHENOLS | 2011 |
|
RU2502719C2 |
PULMONARY METASTASIS INHIBITOR | 2021 |
|
RU2765955C1 |
SULPHUR-CONTAINING 2,6-DIISOBORNYLPHENOL DERIVATIVES | 2014 |
|
RU2568437C1 |
NOVEL DERIVATIVES OF 2,6-DI-ISOBORNYL PHENOL AND METHOD OF OBTAINING THEREOF | 2012 |
|
RU2516699C2 |
METHOD OF PRODUCING 2,9-BIS-SUBSTITUTED TRANS-2,3A,7B,9,10A,14B-HEXAAZAPERHYDRODIBENZOTETRACENES BASED ON AMINO DERIVATIVES OF METHYL ESTER OF MALEOPIMARIC ACID | 2019 |
|
RU2730493C1 |
Authors
Dates
2013-10-27—Published
2012-05-14—Filed